Patients will receive either montelukast or placebo in the treatment of NARES. 4 visits will be conducted over 12 weeks. A history and physical will be performed at the beginning of the trial and at the end. Skin testing will be done at Visit 1. Nasal smears and lavages will be performed at every visit. Patients will be compensated for time and travel.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Aged 18 - 65 years
Diagnosed with NARES
You may not be if
Smokers, exposed to passive smoke
Diagnosis of seasonal allergic rhinitis (SAR), perennial allergic rhinitis (PAR), or vasomotor rhinitis (VMR)
Clareo Health | Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)
